Milestone Pharmaceuticals Closes $55 Million Series C Financing

August 1, 2017

Proceeds to Fund Etripamil Phase 3 Development and Pre-Launch Market Development
More »

Sebacia grabs $36M to push gold microparticle acne treatment through FDA

July 25, 2017

Sebacia, which already markets its gold-and-silica microparticle acne treatment in Europe, raised $36 million to finish a U.S. pivotal trial ahead of an FDA submission expected in 2018.
More »

Iterum Gains Important Support for Development of Novel Oral Antibiotic, Sulopenem

July 25, 2017

CARB-X selects Iterum’s sulopenem to receive $1.5 million investment
More »